IR

Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.

Disclosures

Disclosures

No. Presentation Obligator Date Pubilc Disclosure Writer
1 (주)코아스템 2023.11.23 Material Management Information related to Judgment of Investment(Sponsor-Initiated IND Withdrawal)(항아쿠아포린4 항체 양성 시신경척수염 범주질환 환자에서 동종골수유래 중간엽줄기세포(CE211NS21)와 면역억제제의 병용치료 시 안전성 및 유효성을 평가하기 위한 제1/2a상 임상시험계획승인신청(IND) 반려) CORESTEMCHEMON Inc.
2 (주)코아스템 2023.08.22 Termination of Under-Supervision Issue(반기보고서 미제출 사유 해소) KOSDAQ STOCK MKT.
3 (주)코아스템 2023.08.22 Change of Market Division KOSDAQ STOCK MKT.
4 (주)코아스템 2023.08.14 Designation as Under-Supervision Issue(반기보고서 미제출) KOSDAQ STOCK MKT.
5 (주)코아스템 2023.08.14 Other Management Information(Voluntary Disclosure)(반기보고서 미제출 사유) CORESTEMCHEMON Inc.
6 (주)코아스템 2023.04.26 Material Management Information related to Judgment of Investment(항아쿠아포린4 항체 양성 시신경척수염 범주질환 환자에서 동종골수유래 중간엽줄기세포(CE211NS21)와 면역억제제의 병용치료 시 안전성 및 유효성을 평가하기 위한 제1/2a상 임상시험계획승인신청(IND)) CORESTEMCHEMON Inc.
7 (주)코아스템 2023.03.31 Outcomes of Annual Meeting of Shareholders CORESTEMCHEMON Inc.
8 (주)코아스템 2023.03.22 Submission of Audit Report CORESTEMCHEMON Inc.
9 (주)코아스템 2023.03.06 [Revised]New Facilities Investment, etc. CORESTEMCHEMON Inc.
10 (주)코아스템 2023.02.27 New Facilities Investment, etc. CORESTEMCHEMON Inc.
문의하기